John Cashman Cancer stem cells are one of the main reasons why cancers are able to survive surgery, chemotherapy, and radiation. They are able to hide from those therapies and, at a future date, emerge and spread the cancer in the body once again. Jionglia Cheng, PhD., the lead author of a new CIRM-funded study, … Continue reading Blocking pancreatic cancer stem cells
cancer
Rave reviews for new Killer-T Cell study
Anytime you read a news headline that claims a new discovery "may treat all cancer" it's time to put your skeptic's hat on. After all, there have been so many over-hyped "discoveries" over the years that later flopped, that it would be natural to question the headline writer. And yet, this time, maybe, this one … Continue reading Rave reviews for new Killer-T Cell study
Journalism Pioneer and Founder of Latino Cancer Institute Joins Stem Cell Agency Board
Ysabel Duron Ysabel Duron, a pioneering award-winning Latina journalist, and a leading figure in cancer education in the Latino community in the US, has been appointed to the governing Board of the California Institute for Regenerative Medicine. State Controller Betty Yee made the appointment saying: “Ms. Duron’s personal perspective as a (cancer) survivor and … Continue reading Journalism Pioneer and Founder of Latino Cancer Institute Joins Stem Cell Agency Board
USC study shows how tumor cells in the bloodstream can target distant organs
Various types of cancer can become particularly aggressive and difficult to treat once they spread from their initial point of origin to other parts of the body. This unfortunate phenomenon, known as metastasis, can make treatment very challenging, decreasing the chance of survival for the patient. In order to better understand this process, a CIRM … Continue reading USC study shows how tumor cells in the bloodstream can target distant organs
Predicting the Impact of Stem Cell Cures on Healthcare Burden in California
A new independent report says developing stem cell treatments and cures for some of the most common and deadly diseases could produce multi-billion dollar benefits for California in reduced healthcare costs and improved quality and quantity of life. The report, by researchers at the University of Southern California’s Leonard D. Schaeffer Center for Health Policy … Continue reading Predicting the Impact of Stem Cell Cures on Healthcare Burden in California
Newly discovered “don’t eat me” signal shows potential for ovarian and triple-negative breast cancer treatment
Stanford researchers have found that cancer cells have a protein called CD24 on their surface that enables them to protect themselves against the body's immune cells. Courtesy of Shutterstock Getting a breast cancer diagnosis is devastating news in and of itself. Currently, there are treatment options that target three different types of receptors, which are … Continue reading Newly discovered “don’t eat me” signal shows potential for ovarian and triple-negative breast cancer treatment
Developing a non-toxic approach to bone-crushing cancers
When cancer spreads to the bone the results can be devastating Battling cancer is always a balancing act. The methods we use – surgery, chemotherapy and radiation - can help remove the tumors but they often come at a price to the patient. In cases where the cancer has spread to the bone the treatments … Continue reading Developing a non-toxic approach to bone-crushing cancers
Stories of the week – preterm birth and mice with a human immune system
While we are here at ISSCR 2019 hearing various scientists talk about their work, we realize that there are various breakthroughs in stem cell research in a wide variety of different fields going on every day. It is wonderful to see how scientists are hard at work in developing the latest science and pushing innovation. … Continue reading Stories of the week – preterm birth and mice with a human immune system
First patient treated for colon cancer using reprogrammed adult cells
Dr. Sandip Patel (left) and Dr. Dan Kaufman (center) of UC San Diego School of Medicine enjoy a light-hearted moment before Derek Ruff (right) receives the first treatment for cancer using human-induced pluripotent stem cells (hiPSCs). Photo courtesy of UC San Diego Health. For patients battling cancer for the first time, it can be quite … Continue reading First patient treated for colon cancer using reprogrammed adult cells
New model unlocks clues to treat a deadly childhood cancer
CIRM-funded research at Sanford Burnham Prebys Medical Discovery Institute in San Diego is identifying compounds that could be clues to treat a deadly childhood cancer. A rare brain cancer The cancer is choroid plexus carcinoma (CPC), a rare brain tumor that occurs mainly in children. As it grows the tumor can affect nearby parts of … Continue reading New model unlocks clues to treat a deadly childhood cancer